BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 550328)

  • 1. [Leading trends in the evaluation of programs to control death and incapacitation by cancer of the uterine cervix].
    de la Puente JL
    Salud Publica Mex; 1979; 21(5):573-81. PubMed ID: 550328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of mass colpocytological screening on morbidity and mortality of uterine cervical carcinoma in inhabitants of Parma and experiments on the diagnostic and therapeutic value of conization].
    Salvadori B; Spreafichi F
    Minerva Ginecol; 1975 May; 27(5):413-7. PubMed ID: 1134694
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioisotopes in preliminary screening of cervical cancer.
    Nodine JH; Chang SC; Holmes R; Lewis G; Fletcher M
    J Nucl Med; 1974 Sep; 15(9):733-8. PubMed ID: 4137155
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for cervical cancer.
    Wachtel E
    Practitioner; 1973 Aug; 211(262):137-42. PubMed ID: 4580608
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G; Cariaggi P; Ottaviano M; Marchionni M; Mincione G; Bartoloni St Omer F
    Minerva Ginecol; 1975 May; 27(5):418-21. PubMed ID: 1134695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis of cervical dysplasias].
    Pérez Dettoma J; Santamaría M; Jurado M; Cabezón C; Domínquez J; de la Fuente F; López García G
    Rev Med Univ Navarra; 1980 Dec; 24(4):26-9. PubMed ID: 7336009
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening errors in cervical cytologic screening.
    van der Graaf Y; Vooijs GP; Gaillard HL; Go DM
    Acta Cytol; 1987; 31(4):434-8. PubMed ID: 3604538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of isolated dysplastic and carcinoma in situ type cells in cervical smears from patients with dysplasia and carcinoma in situ: significance to prescreening using image processing techniques.
    Feldman M; Poulsen R; Shepherd L; Marshall KG
    Acta Cytol; 1973; 17(5):395-400. PubMed ID: 4517951
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in colposcopy.
    Navarre GL
    J Reprod Med; 1981 Jan; 26(1):1-4. PubMed ID: 7205805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
    Pairwuti S
    Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Walton report and its subsequent impact on cervical cancer screening programs in Canada.
    Worth AJ
    Obstet Gynecol; 1984 Feb; 63(2):135-9. PubMed ID: 6694805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of dysplasia and in situ cancer of the cervix neck].
    Lambert B
    Union Med Can; 1983 Feb; 112(2):175-7. PubMed ID: 6845558
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytology screening program in an urban and rural community in India. Review of a ten-year experience.
    Garud MA; Saraiya UB; Lulla M; Khan S; Paraskar M; Daftary D
    Acta Cytol; 1983; 27(4):429-31. PubMed ID: 6576543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colposcopy as a screening procedure in the evaluation of abnormal Pap smears.
    Chew SY; Chew SC; Ng WC
    Singapore Med J; 1983 Feb; 24(1):20-2. PubMed ID: 6867761
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer of the uterine cervix: stage 0 and severe dysplasia].
    Walton R; Martínez L; Brañes J; Dabancens A
    Rev Chil Obstet Ginecol; 1985; 50(1):40-8. PubMed ID: 3834534
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogenic effect in vaginal smears in cases of carcinoma in situ and microinvasive carcinoma of the uterine cervix.
    Rubio CA
    Acta Cytol; 1973; 17(4):361-5. PubMed ID: 4198740
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in screening for cancer of the cervix: delivery, technology and evaluation of programs.
    Morgan PP
    Can Med Assoc J; 1982 Oct; 127(7):571-2. PubMed ID: 7127224
    [No Abstract]   [Full Text] [Related]  

  • 19. The yearly Pap test--a necessity for American women.
    Peck SD
    J Am Osteopath Assoc; 1982 May; 81(9):625-31. PubMed ID: 7085371
    [No Abstract]   [Full Text] [Related]  

  • 20. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.